An oncogenic role of hRNase5/ANG in pancreatic cancer through activation EGFR phosphorylation rendered cancer cells more addicted to the EGFR pathway and sensitive to EGFR TKI erlotinib treatment in vitro and in vivo [46]. This evidence concerns the gene ANG and pancreatic neoplasm.